Author Topic: Fentanyl analogue
hypo
Member posted 12-25-1999 10:53 AM
--------------------------------------------------------------------------------
I stumbled on this article: Iwasawa Y. et al: J. Med. Chem. 42/25 (Dec. 16), 1, (1999).
It describes opioid antagonists of fentanyl class. But compound 13 seems to be pretty good, unselective agonist binder (low nanomolar binding constants). The compound has alpha(o-chlorophenethyl) on 1-N (instead of beta phenethyl) and 2-benzimidazolone-1-yl instead of N-phenylpropionamide. Does anyone have an idea how this substitution pattern can affect the bioactivity?
Did anyone try to put an OH group in meta or ortho-position of the aniline phenyl?
Appreciate your input.
This seems to be a very special opioid agonist, because it does not bind to any of the ordinary opioid receptors, but instead the ORL-1 receptor. Read the article at
https://www.thevespiary.org/rhodium/Rhodium/pdf/orl1.agonist.pdf (https://www.thevespiary.org/rhodium/Rhodium/pdf/orl1.agonist.pdf)
Compound 13 is the agonist, the others are antagonists.
This is a nice review of the different kind of opioid receptors:
http://www.tocris.com/opioidreview.htm (http://www.tocris.com/opioidreview.htm)
There are also links to cannabinoid, dopamine, GABA, ... receptors - with a lot of refs.